[1]
M. Winiarska and D. Matosiuk, “Assessment of the new Reimbursement Act functioning between January-November 2012 and its impact on pharmacies and pharmaceutical industry and oncological treatment”, Pol J Public Health, vol. 126, no. 1, pp. 19–23, May 2016, doi: 10.1515/pjph-2016-0004.